Temporal changes in anthropometric parameters and lipid profile according to body mass index among an adult iranian urban population

Annals of Nutrition and Metabolism

Volumn 53, Issue 1, 2008, Pages 13-22

  Bozorgmanesh, Mohammad Reza ^a   Hadaegh, Farzad ^a,b   Padyab, Mojgan ^a   Mehrabi, Yadollah ^a   Azizi, Fereidoun ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anthropometrics; Body mass index; Iranian population; Lipid profile

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANALYSIS OF COVARIANCE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IRAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; URBAN POPULATION; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; ANALYSIS OF VARIANCE; ANTHROPOMETRY; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; IRAN; MALE; MIDDLE AGED; OBESITY; SEX FACTORS; THINNESS; TRIGLYCERIDES; URBAN HEALTH; WAIST CIRCUMFERENCE;

EID: 50849090926     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000152869     Document Type: Article

References (54)

1. ICN National Plan of Action for Nutrition. Teheran, National Nutrition Institute, 1996.
2. Hatmi ZN, Tahvildari S, Gafarzadeh Motlag A, Sabouri Kashani A: Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC Cardiovasc Disord 2007;7:32.
3. Sytkowski PA, D'Agostino RB, Belanger A, Kannel WB: Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study, 1950-1989. Am J Epidemiol 1996;143:338-350.
4. World Health Organization, Eastern Mediterranean Regional Office: Prevention and Control of Cardiovascular Disease. Alexandria, WHO-EMRO, 1995, p 24.
5. Zali M, Kazem M, Masjedi MR: Health and disease in Iran. Bulletin No 10. Tehran, Deputy of Research, Ministry of Health, 1993.
6. American Heart Association: Heart Disease and Stroke Statistics - 2006 Update. Dallas, American Heart Association, 2006.
7. Popkin BM, Gordon-Larsen P: The nutrition transition: worldwide obesity dynamics and their determinants. Int J Obes Relat Metab Disord 2004;28(suppl 3):S2-S9.
8. Prentice AM: The emerging epidemic of obesity in developing countries. Int J Epidemiol 2006;35:93-99.
9. Nishida C, Mucavele P: Monitoring the rapidly emerging public health problem of overweight and obesity: the WHO Global Database on Body Mass Index; in United Nations System Standing Committee on Nutrition: SCN News No. 29: Overweight and Obesity: A New Nutrition Emergency? Geneva, WHO, 2005. http://www.unsystem.org/scn/Publications/SCNNews/scnnews29.pdf.
10. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL: Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994;272:205-211.
11. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP: The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999;282:1519-1522.
12. Allison DB, Fontaine KR, Manson JE, Stevens J, Van Itallie TB: Annual deaths attributable to obesity in the United States. JAMA 1999;282:1530-1538.
13. Johnson CL, Rifkind BM, Sempos CT: Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. JAMA 1993;269:3002-3008.
14. Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, et al: Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 2005;294:1773-1781.
15. Arnett DK, Jacobs DR Jr, Luepker RV, Blackburn H, Armstrong C, Claas SA: Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002. Circulation 2005;112:3884-3891.
16. Wietlisbach V, Paccaud F, Rickenbach M, Gutzwiller F: Trends in cardiovascular risk factors (1984-1993) in a Swiss region: results of three population surveys. Prev Med 1997;26:523-533.
17. Rosengren A, Eriksson H, Larsson B, Svardsudd K, Tibblin G, Welin L, Wilhelmsen L: Secular changes in cardiovascular risk factors over 30 years in Swedish men aged 50: the study of men born in 1913, 1923, 1933 and 1943. J Intern Med 2000;247:111-118.
18. Galobardes B, Costanza MC, Bernstein MS, Delhumeau CH, Morabia A: Trends in risk factors for the major 'lifestyle-related diseases' in Geneva, Switzerland, 1993-2000. Ann Epidemiol 2003;13:537-540.
19. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, Narayan KM, Williamson DF: Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005;293:1918-1919.
20. Wang TD, Chen WJ, Chien KL, Su SSY, Hsu HC, Chen MF, Liau CS, Lee YT: Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population. Am J Cardiol 2001;88:737-743.
21. Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron J, et al: Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med 2001;161:2685-2692.
22. Bersot TP, Pépin GM, Mahley RW: Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol. Am Heart J 2003;146:1052-1059.
23. Azizi F, Azadbakht L, Mirmiran P: Trends in overweight, obesity and central fat accumulation among Tehranian adults between 1998-1999 and 2001-2002: Tehran Lipid and Glucose Study. Ann Nutr Metab 2005;49:3-8.
24. Pishdad GR: Overweight and obesity in adults aged 20-74 in southern Iran. Int J Obes Relat Metab Disord 1996;20:963-965.
25. Azizi F, Rahimi M, Emami H, Majid M: Tehran Lipid and Glucose Study: rationale and design. CVD prevention. Iran J Enodcrinol Metab 2000;3:242-247.
26. Kriska A: Modifiable activity questionnaire. Med Sci Sports Exerc 1997;29:S73-S78.
27. Ainsworth B, Haskell W, Whitt M, Irwin ML, Whitt MC, Leon AS, et al: Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32:S498-S516.
28. Willett WC, Dietz WH, Colditz GA: Guidelines for healthy weight. N Engl J Med 1999;341:427-434.
29. Weinstein AR, Sesso HD, Lee IM, Cook NR, Manson JE, Buring JE, Gaziano JM: Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA 2004;292:1188-1194.
30. Blair SN, LaMonte MJ, Nichaman MZ: The evolution of physical activity recommendations: how much is enough? Am J Clin Nutr 2004;79(suppl):913S-920S.
31. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
32. Berg CM, Lissner L, Aires N, Lappas G, Toren K, Wilhelmsen L, et al: Trends in blood lipid levels, blood pressure, alcohol and smoking habits from 1985 to 2002: results from INTERGENE and GOT-MONICA. Eur J Cardiovasc Prev Rehabil 2005;12:115-125.
33. Ford ES, Mokdad AH, Giles WH, Mensah GA: Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003;107:2185-2189.
34. Arnett DK, McGovern PG, Jacobs DR Jr, Shahar E, Duval S, Blackburn H, Luepker RV: Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997): the Minnesota Heart Survey. Am J Epidemiol 2002;156:929-935.
35. Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-1727.
36. Evans A, Tolonen H, Hense HW, Ferrario M, Sans S, Kuulasmaa K, WHO MONICA Project: Trends in coronary risk factors in the WHO MONICA project. Int J Epidemiol 2001;30(suppl 1):S35-S40.
37. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, et al: A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990;322:882-889.
38. Jackson R, Yee RL, Priest P, Shaw L, Beaglehole R: Trends in coronary heart disease risk factors in Auckland 1982-94. NZ Med J 1995;108:451-454.
39. Hoffmeister H, Mensink GB, Stolzenberg H: National trends in risk factors for cardiovascular disease in Germany. Prev Med 1994;23:197-205.
40. Sternfeld B, Sidney S, Jacobs DR Jr, Sadler MC, Haskell WL, Schreiner PJ: Seven-year changes in physical fitness, physical activity, and lipid profile in the CARDIA study. Coronary Artery Risk Development in Young Adults. Ann Epidemiol 1999;9:25-33.
41. Mittendorfer B, Patterson BW, Klein S: Effect of sex and obesity on basal VLDL-triacylglycerol kinetics. Am J Clin Nutr 2003;77:573-579.
42. Anderson KM, Wilson PW, Garrison RJ, Castelli WP: Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample. The Framingham Offspring Study. Atherosclerosis 1987;68:59-66.
43. Hu D, Hannah J, Gray RS, Jablonski KA, Henderson JA, Robbins DC, Lee ET, Welty TK, Howard BV: Effects of obesity and body fat distribution on lipids and lipoproteins in nondiabetic American Indians: the Strong Heart Study. Obes Res 2000;8:411-421.
44. Ghassemi H, Harrison G, Mohammad K: An accelerated nutrition transition in Iran. Public Health Nutr 2002;5:149-155.
45. Kelishadi R, Ardalan G, Gheiratmand R, Gouya MM, Razaghi EM, Delavari A, Majdzadeh R, et al: Association of physical activity and dietary behaviors in relation to the body mass index in a national sample of Iranian children and adolescents: CASPIAN Study. Bull World Health Organ 2007;85:19-26.
46. Sheikholeslam R, Mohamad A, Mohammad K, Vaseghi S: Non-communicable disease risk factors in Iran. Asia Pac J Clin Nutr 2004;13(suppl):S100.
47. Torabi P, Zare F, Shekholeslam R, Safavi SM: Study of vegetable oil consumption in 15 pilot universities of Iran. Conference proceedings, 12th Nutritional Congress, Tabriz, 2004.
48. Eliasson M, Janlert U, Jansson J-H, Stegmayr B: Time trends in population cholesterol levels 1986-2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study. J Intern Med 2006;260:551-559.
49. Despres JP, Allard C, Tremblay A, Talbor J, Bouchard C: Evidence for regional component of body fatness in the association with serum lipids in men and women. Metabolism 1985;34:967-973.
50. Craig WY, Palomaki GE, Haddow JE: Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989;298:784-788.
51. Von Muhlen D, Langer RD, Barrett-Connor E: Sex and time differences in the associations of non-high-density lipoprotein cholesterol versus other lipid and lipoprotein factors in the prediction of cardiovascular death (the Rancho Bernardo Study). Am J Cardiol 2003;91:1311-1315.
52. Maru S, van der Schouw YT, Gimbrère CHF, Grobbee DE, Peeters PHM: Body mass index and short-term weight change in relation to mortality in Dutch women after age 50 y. Am J Clin Nutr 2004;80:231-236.
53. Warnick GR, Wood PD: National Cholesterol Education Program recommendations for measurement of high-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem 1995;41:1427-1433.
54. Langlois MR, Blaton VH: Historical milestones in measurement of HDL-cholesterol: impact on clinical laboratory practice. Clin Chim Acta 2006;369:168-178.